UNIGE document Scientific Article
previous document  unige:89192  next document
add to browser collection

Impact de la vaccination sur les otites moyennes aiguës

Published in Revue médicale suisse. 2016, vol. 12, no. 506, p. 350-353
Abstract Acute otitis media (AOM) is an important reason for medical visits and antibiotic use in children, with possible complications. Pneumococcal conjugate vaccines (PCV) have been developed from 2000, with first the apparition of the 7-valent PCV (PCV7), and from 2013, of the 13-valent PCV (PCV13). First developed to prevent invasive pneumococcal infections, they have been shown to reduce the number of AOM as well. PC13 has allowed to reduce the nasopharyngeal carriage of the majority of pneumococcal serotypes found in AOM, with a reduction of 77% of pneumococcal AOM, according to one study.
Keywords Acute DiseaseCarrier State/epidemiology/prevention & controlChildHumansNasopharynx/microbiologyOtitis Media/epidemiology/prevention & controlPneumococcal Vaccines/therapeutic useVaccination/methods/statistics & numerical data
PMID: 27039459
Full text
Article (Published version) (644 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Etiologie des pneumonies et marqueurs inflammatoires chez l'enfant fébrile (183)
Recherche en infectiologie pédiatrique et en pédiatrie générale (853)
(ISO format)
BLANCHARD ROHNER, Géraldine, GERVAIX, Alain. Impact de la vaccination sur les otites moyennes aiguës. In: Revue médicale suisse, 2016, vol. 12, n° 506, p. 350-353. https://archive-ouverte.unige.ch/unige:89192

252 hits

1 download


Deposited on : 2016-11-21

Export document
Format :
Citation style :